A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Titel:
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Auteur:
He, Pengcheng Liu, Haibo Zimdahl, Bryan Wang, Jie Luo, Minna Chang, Qi Tian, Fangzhou Ni, Fan Yu, Duo Liu, Huasheng Chen, Limei Wang, Huaiyu Zhang, Mei Grupp, Stephan A. Liu, Cheng